https://www.octapharma.mx/octapharma https://www.octapharma.mx/octapharma/declaracion-privacidad-datos-farmacovigilancia https://www.octapharma.mx/noticias https://www.octapharma.mx/octapharma/contacto https://www.octapharma.mx/octapharma/aviso-privacidad https://www.octapharma.mx/noticias/noticias-corporativas/2019/celebrating-our-milestones https://www.octapharma.mx/noticias/comunicado-prensa/2019/octapharma-demonstrates-commitment-to-improving-haemophilia-a-treatment-at-eahad https://www.octapharma.mx/noticias/historias-de-donantes/2023/mi-hijo-es-un-guerrero https://www.octapharma.mx/noticias/noticias-corporativas/2023/todo-empezo-con-una-conviccion https://www.octapharma.mx/noticias/noticias-corporativas/2019/update-of-summary-of-product-characteristics-for-nuwiq https://www.octapharma.mx/noticias/nuestros-empleados/2018/from-childhood-dream-to-research-team https://www.octapharma.mx/noticias/comunicado-prensa/2019/positive-results-for-fibryga-published-in-the-journal-of-thrombosis-and-haemostasis https://www.octapharma.mx/noticias/historias-de-donantes/2023/sin-plasma-no-estaria-viva-ahora https://www.octapharma.mx/octapharma/declaracion-legal https://www.octapharma.mx/noticias/historias-de-pacientes/2020/always-on-the-go https://www.octapharma.mx/noticias/noticias-corporativas/2019/octapharma-group-reports-strong-results-for-2018 https://www.octapharma.mx/noticias/noticias-corporativas/2018/octapharma-group-publishes-2017-annual-results https://www.octapharma.mx/noticias/nuestros-empleados/2018/persistence-and-ingenuity-pays-off https://www.octapharma.mx/noticias/innovacion-y-ciencia/2018/timely-help-for-critically-ill-patients https://www.octapharma.mx/noticias/comunicado-prensa/2019/final-results-from-the-nuprotect-study-demonstrating-efficacy-of-nuwiq https://www.octapharma.mx/productos/producto-resumen https://www.octapharma.mx/noticias/historias-de-pacientes/2023/transfundir-o-no https://www.octapharma.mx/noticias/historias-de-pacientes/2020/why-worry- https://www.octapharma.mx/noticias/noticias-corporativas/2017/octapharma-group-publishes-2016-annual-results https://www.octapharma.mx/noticias/noticias-corporativas/2019/new-data-on-haemophilia-a-or-von-willebrand-disease-at-isth-2019 https://www.octapharma.mx/noticias/noticias-corporativas/2018/octapharma-share-promising-preclinical-data-for-subq-8 https://www.octapharma.mx/noticias/nuestros-empleados/2018/medicine-as-an-art-form https://www.octapharma.mx/noticias/innovacion-y-ciencia/2020/trust-swift-decision-making-and-excellent-medical-skills-are-a-priority-for-intensive-care https://www.octapharma.mx/noticias/innovacion-y-ciencia/2018/low-inhibitor-rate-with-octanate-in-previously-untreated-patients https://www.octapharma.mx/noticias/comunicado-prensa/2019/final-results-from-the-nuprotect-study https://www.octapharma.mx/compromiso/compromiso-del-paciente/compromiso-del-paciente https://www.octapharma.mx/noticias/innovacion-y-ciencia/2023/motivados-por-la-curiosidad https://www.octapharma.mx/noticias/historias-de-pacientes/2023/viviendo-con-el-misterio-de-la-dermatomiositis https://www.octapharma.mx/noticias/historias-de-pacientes/2020/a-passion-for-living https://www.octapharma.mx/noticias/noticias-corporativas/2017/octapharma-activities-prominent-at-the-upcoming-2017-isth-congress https://www.octapharma.mx/noticias/noticias-corporativas/2019/update-on-the-development-of-subq-8-isth-2019 https://www.octapharma.mx/noticias/noticias-corporativas/2020/continuing-to-invest-in-the-future-prosperity-of-octapharma https://www.octapharma.mx/noticias/noticias-corporativas/2018/octapharma-to-build-new-multi-use-venue https://www.octapharma.mx/noticias/nuestros-empleados/2018/using-big-data-to-improve-lives https://www.octapharma.mx/noticias/nuestros-empleados/2020/adam-llarena-single-donation-controller https://www.octapharma.mx/noticias/innovacion-y-ciencia/2020/the-story-of-octapharmas-high-purity-human-fibrinogen-concentrate https://www.octapharma.mx/noticias/innovacion-y-ciencia/2018/octapharma-present-new-data-on-the-benefits-of-nuwiq https://www.octapharma.mx/noticias/comunicado-prensa/2019/fibryga-receives-european-label-extension-to-treat-acquired-fibrinogen-deficiency-afd https://www.octapharma.mx/sobre-nosotros/quienes-somos https://www.octapharma.mx/productos https://www.octapharma.mx/ https://www.octapharma.mx/noticias/noticias-corporativas/2025/analisis-financiero-2024 https://www.octapharma.mx/noticias/innovacion-y-ciencia/2023/una-cultura-empresarial https://www.octapharma.mx/noticias/historias-de-pacientes/2022/el-largo-camino-hasta-el-diagnostico-de-dermatomiositis https://www.octapharma.mx/noticias/historias-de-pacientes/2022/viviendo-con-la-enfermedad-de-von-Willebrand https://www.octapharma.mx/noticias/historias-de-pacientes/2022/el-pbm-es-la-clave-del-exito-de-la-separacion-de-gemelas-siamesas https://www.octapharma.mx/noticias/historias-de-pacientes/2023/el-sueno-de-formar-una-familia-a-pesar-de-la-VWD https://www.octapharma.mx/noticias/historias-de-pacientes/2020/surviving-the-unknown https://www.octapharma.mx/noticias/historias-de-pacientes/2018/engaging-with-patients https://www.octapharma.mx/noticias/noticias-corporativas/2017/octapharma-symposium-at-isth-berlin https://www.octapharma.mx/noticias/noticias-corporativas/2019/new-data-isth-2019 https://www.octapharma.mx/noticias/noticias-corporativas/2020/continuing-the-impact-of-our-products-for-generations-to-come https://www.octapharma.mx/noticias/nuestros-empleados/2018/an-eye-for-detail https://www.octapharma.mx/noticias/nuestros-empleados/2020/we-are-octapharma https://www.octapharma.mx/noticias/innovacion-y-ciencia/2020/testing-boundaries https://www.octapharma.mx/noticias/innovacion-y-ciencia/2018/octapharma-announces-approval-of-new-nuwiq-product-strengths https://www.octapharma.mx/noticias/comunicado-prensa/2019/octapharma-announces-publication-of-data-on-fibryga https://www.octapharma.mx/noticias/comunicado-prensa/2020/octapharma-group-delivered-strong-growth-in-both-sales-and-operating-income-in-2019 https://www.octapharma.mx/plasma https://www.octapharma.mx/noticias/noticias-corporativas/2025/construido-sobre-la-fuerza-y-la-resiliencia https://www.octapharma.mx/noticias/historias-de-pacientes/2017/octapharma-usa-sponsors-hope-ignites-stories-to-inspire https://www.octapharma.mx/noticias/historias-de-pacientes/2018/real-hope-for-brandon https://www.octapharma.mx/noticias/historias-de-pacientes/2016/blood-is-essential-for-the-wellbeing-of-everyone https://www.octapharma.mx/noticias/nuestros-empleados/2018/getting-our-medicines-to-patients https://www.octapharma.mx/noticias/nuestros-empleados/2017/bringing-new-optimal-therapies https://www.octapharma.mx/noticias/innovacion-y-ciencia/2017/isth-2017-berlin-octapharma-presents-exciting-nuwiq-data https://www.octapharma.mx/noticias/innovacion-y-ciencia/2018/octapharma-receives-swissmedic-approval-for-fibryga https://www.octapharma.mx/sobre-nosotros/enfermedades-y-terapias https://www.octapharma.mx/sobre-nosotros https://www.octapharma.mx/bolsa-de-trabajo https://www.octapharma.mx/compromiso/eventos-internacionales/eventos-internacionales https://www.octapharma.mx/compromiso https://www.octapharma.mx/noticias/historias-de-pacientes/2017/octapharma-usa-sponsors-nhf-annual-meeting https://www.octapharma.mx/noticias/historias-de-pacientes/2018/strong-commitment-for-the-two-brothers-from-estonia https://www.octapharma.mx/noticias/historias-de-pacientes/2016/one-in-ten-patients https://www.octapharma.mx/noticias/nuestros-empleados/2016/saving-lives https://www.octapharma.mx/noticias/nuestros-empleados/2017/inspecting-finished-products https://www.octapharma.mx/noticias/innovacion-y-ciencia/2017/octapharma-underlines-strong-commitment-to-haemophilia-a-patients https://www.octapharma.mx/noticias/innovacion-y-ciencia/2018/new-canadian-study-to-improve-eradication-of-inhibitors https://www.octapharma.mx/sobre-nosotros/quienes-somos/liderazgo https://www.octapharma.mx/sobre-nosotros/enfermedades-y-terapias/hematologia https://www.octapharma.mx/bolsa-de-trabajo/vacantes https://www.octapharma.mx/noticias/historias-de-pacientes/2017/octapharma-usa-grant-supports-mission-of-first-hemophiliac-to-climb-the-seven-summits-of-the-world https://www.octapharma.mx/noticias/historias-de-pacientes/2016/i-am-lucky-to-be-alive https://www.octapharma.mx/noticias/nuestros-empleados/2017/preserving-human-proteins https://www.octapharma.mx/noticias/innovacion-y-ciencia/2017/publication-of-clinical-data-demonstrating-low-immunogenicity-and-excellent-efficacy-of-nuwiq https://www.octapharma.mx/sobre-nosotros/quienes-somos/hitos https://www.octapharma.mx/sobre-nosotros/enfermedades-y-terapias/immunoterapia https://www.octapharma.mx/bolsa-de-trabajo/como-postular https://www.octapharma.mx/productos/proceso-produccion https://www.octapharma.mx/compromiso/compromiso-del-paciente-global https://www.octapharma.mx/compromiso/eventos-global https://www.octapharma.mx/noticias/historias-de-pacientes/2017/octapharma-donates-30-5-million-international-units-of-its-medicine https://www.octapharma.mx/noticias/historias-de-pacientes/2016/there-is-always-time-in-life-for-an-adventure https://www.octapharma.mx/noticias/nuestros-empleados/2017/investing-to-increase-capacity-and-automation https://www.octapharma.mx/sobre-nosotros/enfermedades-y-terapias/cuidado-critico https://www.octapharma.mx/sobre-nosotros/investigacion-y-desarrollo https://www.octapharma.mx/bolsa-de-trabajo/aprendizaje-y-desarrollo https://www.octapharma.mx/productos/calidad-y-seguridad https://www.octapharma.mx/noticias/historias-de-pacientes/2017/donors-like-my-father https://www.octapharma.mx/noticias/historias-de-pacientes/2016/it-is-as-if-a-big-hammer-falls-down-on-you https://www.octapharma.mx/noticias/nuestros-empleados/2017/purifying-products https://www.octapharma.mx/bolsa-de-trabajo/trabajo-en-octapharma https://www.octapharma.mx/noticias/historias-de-pacientes/2017/donating-plasma https://www.octapharma.mx/noticias/historias-de-pacientes/2016/my-illness-has-given-me-the-will-to-live https://www.octapharma.mx/noticias/nuestros-empleados/2017/cultivating-factor-viii https://www.octapharma.mx/sobre-nosotros/nuestras-ubicaciones https://www.octapharma.mx/noticias/historias-de-pacientes/2016/when-i-am-dancing-i-feel-free https://www.octapharma.mx/noticias/nuestros-empleados/2017/validating-cleaning-methods https://www.octapharma.mx/noticias/historias-de-pacientes/2016/a-hyperactive-kid-with-haemophilia-is-a-dangerous-cocktail https://www.octapharma.mx/noticias/nuestros-empleados/2017/getting-the-right-material https://www.octapharma.mx/noticias/historias-de-pacientes/2016/the-tainted-blood-scandal-was-hugely-tragic-but-very-instructive- https://www.octapharma.mx/noticias/nuestros-empleados/2017/separating-plasma-proteins https://www.octapharma.mx/noticias/historias-de-pacientes/2016/i-never-let-haemophilia-dictate-how-i-live-my-life https://www.octapharma.mx/noticias/nuestros-empleados/2017/maintaining-the-cold-chain https://www.octapharma.mx/noticias/nuestros-empleados/2017/around-the-clock-production https://www.octapharma.mx/noticias/historias-de-pacientes/2016/i-want-to-be-a-superhero https://www.octapharma.mx/noticias/nuestros-empleados/2017/documenting-the-complete-history-of-every-production-batch https://www.octapharma.mx/noticias/historias-de-pacientes/2016/haemophilia-is-just-a-part-of-who-my-sons-are https://www.octapharma.mx/noticias/nuestros-empleados/2017/performing-analytical-methods https://www.octapharma.mx/noticias/nuestros-empleados/2017/detecting-viruses-early https://www.octapharma.mx/noticias/nuestros-empleados/2017/ensuring-safety-and-suitability-of-donors https://www.octapharma.mx/noticias/nuestros-empleados/2017/controlling-the-plasma https://www.octapharma.mx/noticias/nuestros-empleados/2017/research-that-helps-people